Bretton Capital Management LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) during the third quarter, Holdings Channel reports. The firm purchased 9,800 shares of the healthcare conglomerate’s stock, valued at approximately $5,730,000. UnitedHealth Group accounts for 5.5% of Bretton Capital Management LLC’s portfolio, making the stock its 6th largest position.
Several other institutional investors and hedge funds have also bought and sold shares of UNH. Kathleen S. Wright Associates Inc. acquired a new stake in shares of UnitedHealth Group during the 3rd quarter worth approximately $27,000. Macroview Investment Management LLC boosted its holdings in shares of UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares in the last quarter. Delos Wealth Advisors LLC lifted its position in shares of UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 53 shares during the last quarter. Bbjs Financial Advisors LLC acquired a new position in UnitedHealth Group during the second quarter worth about $31,000. Finally, Global Wealth Strategies & Associates grew its holdings in shares of UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.
Wall Street Analyst Weigh In
A number of analysts have weighed in on the stock. TD Cowen boosted their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Royal Bank of Canada dropped their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Tuesday. HSBC cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. Finally, Argus increased their price objective on UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Three equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.
UnitedHealth Group Stock Down 1.4 %
UnitedHealth Group stock opened at $605.88 on Thursday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $557.58 billion, a PE ratio of 39.47, a PEG ratio of 1.80 and a beta of 0.58. The firm’s fifty day moving average is $582.99 and its 200 day moving average is $548.03.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm’s revenue was up 9.2% compared to the same quarter last year. During the same period in the previous year, the company posted $6.56 EPS. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.39%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
- Five stocks we like better than UnitedHealth Group
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Top 3 R&D-Driven Stocks Showing Strong Profit and Momentum
- Trading Halts Explained
- Shopify Stock Rally Continues: Why the Growth Story Isn’t Over
- Business Services Stocks Investing
- Tariff Troubles: 3 Stocks Planning Higher Prices
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.